The President & COO of MiMedx Group is Exercising Options

By Carrie Williams

Today, the President & COO of MiMedx Group, William Charles Taylor, exercised options of MiMedx Group for $33K.

Following this transaction William Charles Taylor’s holding in the company was increased by 3.72% to a total of $3.95 million.

Based on MiMedx Group’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $84.57 million and quarterly net profit of $17.46 million. In comparison, last year the company earned revenue of $69.88 million and had a net profit of $5.48 million. The company has a one-year high of $18.25 and a one-year low of $6.05. MDXG’s market cap is $807.2M and the company has a P/E ratio of 22.87.

Based on 4 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $18.5, reflecting a -61.7% downside. Seven different firms, including Canaccord Genuity and Craig-Hallum, currently also have a Buy rating on the stock.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MiMedx Group, Inc. is a biopharmaceutical company. It engages in the design, manufacture, and marketing of regenerative biomaterials products and tissue processing services for the wound care, surgical, sports medicine, ophthalmic and dental market categories.